Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Brain Stem Neoplasms × Piperazine × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Oligodendroglioma 1 Medulloblastoma 1 Glioma 1 Glioblastoma 1 Diffuse Intrinsic Pontine Glioma 1 Brain Stem Neoplasms 1 Astrocytoma 1

Interventions

rofecoxib 1 rindopepimut 1 ovex 1 imetelstat 1 entinostat 1 azurin (50-77) 1 Thalidomide 1 Re-Irradiation 1 Piperazine 1 Mebendazole 1 Irinotecan 1 GRN163L peptide 1 Cisplatin 1 Carboplatin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02644291 2022-06-23

Phase I Study of Mebendazole Therapy for Recurrent/Progressive Pediatric Brain Tumors

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Phase 1 Completed

Diffuse Intrinsic Pontine Glioma, Astrocytoma, Glioblastoma, Glioma, Medulloblastoma, Oligodendroglioma, Brain Stem Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡